These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1728 related items for PubMed ID: 10648030

  • 1. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K, Hoch S, Dima C, Varga J, Teodorescu M.
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [Abstract] [Full Text] [Related]

  • 2. Anti-CENP-B response in sera of uranium miners exposed to quartz dust and patients with possible development of systemic sclerosis (scleroderma).
    Conrad K, Stahnke G, Liedvogel B, Mehlhorn J, Barth J, Blasum C, Altmeyer P, Sönnichsen N, Frank KH.
    J Rheumatol; 1995 Jul; 22(7):1286-94. PubMed ID: 7562760
    [Abstract] [Full Text] [Related]

  • 3. [Clinical significance of anti-centromere antibody and anti-CENP-B antibody in sera of patients with primary biliary cirrhosis].
    Onozuka Y, Shibata M, Yonezawa H, Terauti K, Miyachi K, Ueno Y.
    Rinsho Byori; 1996 Sep; 44(9):877-82. PubMed ID: 8911074
    [Abstract] [Full Text] [Related]

  • 4. Anticentromere autoantibodies in patients without Raynaud's disease or systemic sclerosis.
    Vázquez-Abad D, Grodzicky T, Senécal JL.
    Clin Immunol; 1999 Feb; 90(2):182-9. PubMed ID: 10080829
    [Abstract] [Full Text] [Related]

  • 5. Anti-centromere antibodies in a large cohort of systemic sclerosis patients: comparison between immunofluorescence, CENP-A and CENP-B ELISA.
    Mahler M, You D, Baron M, Taillefer SS, Hudson M, Canadian Scleroderma Research Group(CSRG), Fritzler MJ.
    Clin Chim Acta; 2011 Oct 09; 412(21-22):1937-43. PubMed ID: 21756890
    [Abstract] [Full Text] [Related]

  • 6. The concurrence of rheumatoid arthritis and limited systemic sclerosis: clinical and serologic characteristics of an overlap syndrome.
    Zimmermann C, Steiner G, Skriner K, Hassfeld W, Petera P, Smolen JS.
    Arthritis Rheum; 1998 Nov 09; 41(11):1938-45. PubMed ID: 9811047
    [Abstract] [Full Text] [Related]

  • 7. Clinical significance of anticentromere antibodies in patients with systemic lupus erythematosus.
    Nakano M, Ohuchi Y, Hasegawa H, Kuroda T, Ito S, Gejyo F.
    J Rheumatol; 2000 Jun 09; 27(6):1403-7. PubMed ID: 10852261
    [Abstract] [Full Text] [Related]

  • 8. High frequency of neoplasia in patients with autoantibodies to centromere protein CENP-F.
    Rattner JB, Rees J, Whitehead CM, Casiano CA, Tan EM, Humbel RL, Conrad K, Fritzler MJ.
    Clin Invest Med; 1997 Oct 09; 20(5):308-19. PubMed ID: 9336656
    [Abstract] [Full Text] [Related]

  • 9. High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases.
    Santoro P, De Andrea M, Migliaretti G, Trapani C, Landolfo S, Gariglio M.
    J Rheumatol; 2002 Jan 09; 29(1):90-3. PubMed ID: 11824977
    [Abstract] [Full Text] [Related]

  • 10. Decreased levels of autoantibody against histone deacetylase 3 in patients with systemic sclerosis.
    Kuwatsuka Y, Ogawa F, Iwata Y, Komura K, Muroi E, Hara T, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Sato S.
    Autoimmunity; 2009 Feb 09; 42(2):120-5. PubMed ID: 19021012
    [Abstract] [Full Text] [Related]

  • 11. CENP-O, a protein localized at the centromere throughout the cell cycle, is a novel target antigen in systemic sclerosis.
    Saito A, Muro Y, Sugiura K, Ikeno M, Yoda K, Tomita Y.
    J Rheumatol; 2009 Apr 09; 36(4):781-6. PubMed ID: 19286853
    [Abstract] [Full Text] [Related]

  • 12. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S, Asanuma H, Nishiyama S, Yoshinaga Y.
    J Rheumatol; 2005 Aug 09; 32(8):1488-94. PubMed ID: 16078324
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
    Damoiseaux J, Boesten K, Giesen J, Austen J, Tervaert JW.
    Ann N Y Acad Sci; 2005 Jun 09; 1050():340-7. PubMed ID: 16014550
    [Abstract] [Full Text] [Related]

  • 14. A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16.
    Mondini M, Vidali M, De Andrea M, Azzimonti B, Airò P, D'Ambrosio R, Riboldi P, Meroni PL, Albano E, Shoenfeld Y, Gariglio M, Landolfo S.
    Arthritis Rheum; 2006 Dec 09; 54(12):3939-44. PubMed ID: 17133607
    [Abstract] [Full Text] [Related]

  • 15. Anti-p53 autoantibody in systemic sclerosis: association with limited cutaneous systemic sclerosis.
    Hara T, Ogawa F, Muroi E, Komura K, Takenaka M, Hasegawa M, Fujimoto M, Sato S.
    J Rheumatol; 2008 Mar 09; 35(3):451-7. PubMed ID: 18203319
    [Abstract] [Full Text] [Related]

  • 16. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.
    Jimenez-Boj E, Kedersha N, Tohidast-Akrad M, Karlhofer FM, Stummvoll G, Zimmermann C, Ulrich W, Guiducci S, Hoefler E, Aringer M, Schett G, Matucci-Cerinic M, Smolen JS, Steiner G.
    Arthritis Rheum; 2008 May 09; 58(5):1226-36. PubMed ID: 18438838
    [Abstract] [Full Text] [Related]

  • 17. Recognition of Granzyme B-generated autoantigen fragments in scleroderma patients with ischemic digital loss.
    Schachna L, Wigley FM, Morris S, Gelber AC, Rosen A, Casciola-Rosen L.
    Arthritis Rheum; 2002 Jul 09; 46(7):1873-84. PubMed ID: 12124872
    [Abstract] [Full Text] [Related]

  • 18. Anti-lipoprotein lipase antibody in systemic sclerosis: association with elevated serum triglyceride concentrations.
    Kodera M, Hayakawa I, Komura K, Yanaba K, Hasegawa M, Takehara K, Sato S.
    J Rheumatol; 2005 Apr 09; 32(4):629-36. PubMed ID: 15801017
    [Abstract] [Full Text] [Related]

  • 19. Clinical correlates of CENP-A and CENP-B antibodies in a large cohort of patients with systemic sclerosis.
    Hudson M, Mahler M, Pope J, You D, Tatibouet S, Steele R, Baron M, Investigators of the Canadian Scleroderma Research Group, Fritzler M.
    J Rheumatol; 2012 Apr 09; 39(4):787-94. PubMed ID: 22467948
    [Abstract] [Full Text] [Related]

  • 20. Anti-agalactosyl IgG antibodies in sera from patients with systemic sclerosis.
    Nishijima C, Sato S, Takehara K.
    J Rheumatol; 2001 Aug 09; 28(8):1847-51. PubMed ID: 11508588
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 87.